Trial reportRevista medica del Instituto Mexicano del Seguro Social2024
[Fat graft and platelet-rich plasma versus fat alone myringoplasty].
Trial report in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Myringoplasty is the most effective method for the closure of chronic tympanic perforations, fat graft as support for epithelialization has a low success rate for perforations > 30%, the use of platelet-rich plasma promises an adjuvant role in the regeneration of the tympanic membrane in perforations > 25% and <50%. Objective: To demonstrate the rate of successful of myringoplasty with fat graft with platelet-rich plasma in tympanic membrane perforations less than 50% compared to fat graft alone. Material and methods: Clinical, randomized, controlled study. 60 patients were included with perforation of less than 50%, both sexes, without active infection, suspicion of ossicular pathology or history of mastoidectomy. Divided into two groups: Group A, 30 patients who underwent myringoplasty with fat graft and Group B, 30 patients with the same technique and platelet-rich plasma. Groups were subdivided by perforation size: Subgroup 1 (0-25%) and Subgroup 2 (26-50%). Results: At one month of postsurgical follow up, the tympanic membrane perforation closure success rate was significantly higher in group B compared to group A, p = 0.047. Subgroup 1: closure of 56% and 66.6% for group A and B, subgroup 2: with 0 and 13%. Conclusions: Myringoplasty with fat graft with platelet-rich plasma enriched is recommended as a treatment option for first line of medium-sized tympanic perforations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.